Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy FDA accelerated approval ,Office of Inspector General ,aducanumab approval,clinical trial data,alzheimer disease hemophilia a

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Aplagon secures EUR 7 million for APAC phase 2a trials - about 2 months ago
2	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	4 closely watched FDA approval dates in 2025 from J&J, Novo and more - 3 months ago Has pharma emerged from the ‘age of uncertainty’? - 9 months ago The FDA pushes concrete plans to further diversity in clinical trials - 9 months ago After 33 years, Geron’s first approval marks a turn in Nobel-winning science - 9 months ago 4 big FDA approval dates to watch in 2024 - about 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - 4 months ago Despite adcomm rejection, Lykos CEO sees future for MDMA drug - 10 months ago After Amylyx drug failure, what’s next for ALS? - about 1 year ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - about 1 year ago 3 recent FDA adcomm rejections — and why they matter - over 1 year ago
4	Elise Reuter Healthcare Dive Reporter @MedTechDive. Covers medical devices. medical technologydigital therapeutics	FDA issues final guidance on postmarket updates to AI-enabled devices - 4 months ago FDA issues final guidance on postmarket updates to AI-enabled devices - 4 months ago FDA drafts guidance outlining real-world evidence for medical device submissions - over 1 year ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator - 4 months ago FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 7 months ago Better Prevention Strategies Rely on the Monitoring of Outpatient Adverse Drug Events - 9 months ago Samsung Bioepis Initiates Phase 1 Trial for Proposed Keytruda Biosimilar - about 1 year ago
6	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: Merck says study of under-the-skin version of Keytruda, a bid to extend the drug’s sales, succeeded - 5 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings - 5 months ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: With new Wegovy data in hand, Novo Nordisk will file for approval in MASH - 5 months ago
9	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Helsinki Declaration says researchers must disclose trial results on a timely basis - 5 months ago STAT+: European Parliament votes in favor of updated pharma legislation, prompting mixed reactions - 12 months ago STAT+: FDA agrees to review a rare disease drug that its developer was about to give up on - 12 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - about 1 year ago STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - over 1 year ago STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors - over 1 year ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - over 1 year ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - over 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - over 1 year ago
10	Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area Healthcare journalism	Use of Prior Authorization Up in Medicare Advantage Plans, Senate Report Finds - 6 months ago

Journalists covering post-approval phase